Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Kareus Therapeutics SA, the company focused on the development of novel therapeutics to address high unmet medical need, today announced a broad strategic alliance with Quintiles to progress the development of two of Kareus' pre-clinical programs through clinical trials.

13 Jun 2011

Mortality from all causes higher among hepatitis C-infected patients, study finds

Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases and now available online sought to determine mortality from all causes, including liver- and non-liver related deaths among hepatitis C patients in the general U.S. population. The analysis found mortality from all causes to be higher in these patients.

10 Jun 2011

Larger trial study needed to decide fate of niacin

Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol).

10 Jun 2011

Inspire's Stimulation Therapy for Apnea Reduction trial reaches milestones

Inspire Medical Systems, the leading developer of neurostimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today The STAR trial, evaluating both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy, is currently underway at 9 leading medical centers across the United States and at 4 sites in Europe.

10 Jun 2011

Researchers develop new imaging technology to detect cardiovascular disease

Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser.

10 Jun 2011

Exercise protects against silent stroke: Study

Strokes can cause brain damage by cutting off blood flow to the brain. But unlike major strokes, recognizable by symptoms such as weakness on one side of the body and trouble speaking, so-called silent strokes by definition go unnoticed. Symptoms can include subtle memory and mobility problems, as well as an increased risk for future strokes, according to the American Academy of Neurology. Silent strokes are also different from mini-strokes, which are noticeable but last only for minutes or hours.

9 Jun 2011

Being a young man is risky business for health

The Royal Australian College of General Practitioners (RACGP) is highlighting that young Australian men have higher rates of risky behaviours than young women and that this can put their health at immediate and long term risk. This warning comes as International Men’s Health Week takes place from 13 – 19 June 2011.

9 Jun 2011

New bariatric bed

Twenty-percent of the adult U.S. population is obese, including approximately five percent that are considered morbidly obese. The direct health issues, related complications and safety challenges affecting this population are far reaching and well documented. VitalGo, Inc., a provider of advanced technology-based solutions for medical staff safety, patient safety and home care, has announced the immediate availability of the new bariatric version of its Total Lift Bed™ (TLB) which addresses a wide variety of care, treatment and safety issues for patients weighing up to 1,000 lbs.

9 Jun 2011

National survey finds women more likely to see doctor on regular basis than men

A national survey found that women were three times more likely to see a doctor on a regular basis than men. Even though men on average die younger than women and have higher mortality rates for heart disease, cancer, stroke and AIDS, trying to get a man to a doctor can be harder than pulling teeth. So, why do men hate it so?.

9 Jun 2011

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.

9 Jun 2011

More women than men are unnecessarily referred for nuclear stress tests

New research from cardiologists at Rhode Island and The Miriam hospitals suggests a possible gender disparity in how patients are referred for nuclear stress tests, an imaging technique that measures blood flow to the heart muscle both at rest and during periods of stress, such as exercise.

9 Jun 2011

Drug that makes the failing heart heal itself

Researchers have found that a drug can heal heart muscles in mice. Earlier it was considered that this damage to the heart is permanent but this new findings refutes earlier beliefs.

9 Jun 2011

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America.

8 Jun 2011

Einstein health expert plays an important role in development of U.S. News 'Best Diets' rankings

Yasmin Mossavar-Rahmani, Ph.D., R.D. of Albert Einstein College of Medicine of Yeshiva University played an important role in the development of the "Best Diets" rankings, which U.S. News released today.

8 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

Novel technique promises to reduce damage after heart attack

Scientists at the University of Leicester are investigating a novel technique that promises to protect heart muscle from life-threatening damage following a heart attack - simply by squeezing an arm. Heart attacks are the major cause of premature death in England, with massive implications for survival and costs of long-term health care.

7 Jun 2011

Race impacts risk of heart disease after gestational diabetes

New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.

7 Jun 2011

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

7 Jun 2011

ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.

6 Jun 2011

U of A researchers try to combat heart disease in cancer patients

Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.

4 Jun 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Mortality from all causes higher among hepatitis C-infected patients, study finds

Larger trial study needed to decide fate of niacin

Inspire's Stimulation Therapy for Apnea Reduction trial reaches milestones

Researchers develop new imaging technology to detect cardiovascular disease

Exercise protects against silent stroke: Study

Being a young man is risky business for health

New bariatric bed

National survey finds women more likely to see doctor on regular basis than men

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

More women than men are unnecessarily referred for nuclear stress tests

Drug that makes the failing heart heal itself

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

Einstein health expert plays an important role in development of U.S. News 'Best Diets' rankings

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Novel technique promises to reduce damage after heart attack

Race impacts risk of heart disease after gestational diabetes

Non-steroidal, oral contraceptive for men

ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

U of A researchers try to combat heart disease in cancer patients

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in